Shukra Pharmaceuticals Limited (BOM:524632)
18.12
-0.74 (-3.92%)
At close: Apr 24, 2025
Shukra Pharmaceuticals Revenue
Shukra Pharmaceuticals had revenue of 115.91M INR in the quarter ending December 31, 2024, a decrease of -40.42%. This brings the company's revenue in the last twelve months to 333.97M, down -70.11% year-over-year. In the fiscal year ending March 31, 2024, Shukra Pharmaceuticals had annual revenue of 764.66M with 28.53% growth.
Revenue (ttm)
333.97M
Revenue Growth
-70.11%
P/S Ratio
22.58
Revenue / Employee
1.84M
Employees
182
Market Cap
7.54B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 764.66M | 169.73M | 28.53% |
Mar 31, 2023 | 594.93M | 390.07M | 190.41% |
Mar 31, 2022 | 204.86M | 92.90M | 82.97% |
Mar 31, 2021 | 111.96M | -6.50M | -5.49% |
Mar 31, 2020 | 118.46M | 61.86M | 109.31% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,646.93B |
HDFC Bank | 2,728.47B |
Tata Consultancy Services | 2,553.24B |
Bharti Airtel | 1,627.08B |
ICICI Bank | 2,006.54B |
State Bank of India | 3,409.52B |
Infosys | 1,647.16B |
Bajaj Finance | 358.05B |
Shukra Pharmaceuticals News
- 3 months ago - Shukra Pharmaceuticals shares surge 90% in past one month; Check details - Business Upturn
- 3 months ago - Shukra Pharmaceuticals shares surge 166% in past one month; Check details - Business Upturn